Skip to main content

Peer Review reports

From: Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Original Submission
30 Aug 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
27 Apr 2015 Editorially accepted
11 May 2015 Article published 10.1186/s12885-015-1373-z

You can find further information about peer review here.

Back to article page